Biodesix Webinar | Digital Event

Biodesix

A New Era in Precision Medicine - Uncovering the Depth & Breadth of the Plasma Proteome with Novel Proteomic Technologies

This event ran Tuesday June 22, 2021 | 11:00am EDT | 8:00am PDT

The June Biodesix Webinar will Cover:

A New Era in Precision Medicine - Uncovering the Depth & Breadth of the Plasma Proteome with Novel Proteomic Technologies

 

Welcome to the Biodesix Webinar, an exclusive event providing leaders in biopharma and academia with the opportunity to explore how new technologies are enabling researchers to see deeper and broader into the plasma proteome than ever before.

Providing perspectives from leading experts in the field, join this webinar to learn how Seer’s Proteograph™ Product Suite enables the uncovering of more proteins without the need for upfront depletion and fractionation steps. Plus, examine the challenges and current state of biomarker and translational research, and discover how to stay ahead of the curve by hearing key considerations on how to obtain novel insights on biological processes.

KEY TAKEAWAYS

  • Identify how and why proteomics are the next frontier in biomarker and translational research. Dive deep into the challenges faced by researchers and the solutions to overcome them
  • Better understand how new technologies are changing the biomarker and translational research to enable deeper and broader insights into the plasma proteome
  • Learn how Seer’s Proteograph™ Product Suite which uses nanoparticle-based enrichment of plasma proteins, enables researchers to uncover more proteins without the need for upfront depletion and fractionation steps
  • Understand how Biodesix, a clinical diagnostic testing laboratory specialized in proteomics, is integrating Seer’s Proteograph™ Product Suite into their mass spectrometry-based workflows for biopharmaceutical and academic research services

EXPERT SPEAKERS

WHO SHOULD ATTEND

This is an event for executives from Immuno-Oncology, Oncology, Translational Medicine & Companion Diagnostic departments of biopharma and academic institutions looking to improve their biomarker and translational research. Dive deep into how these technologies can provide biopharma and academic researchers with novel insights and a deeper understanding of biological processes.

ABOUT BIODESIX

Biodesix is a leading data-driven diagnostic solutions company helping answer critical clinical questions faced by physicians, researchers, and biopharmaceutical companies, with a primary focus in lung disease. Our core belief is that no single technology will answer all clinical questions that we encounter. Therefore, we employ multiple technologies and leverage our proprietary artificial intelligence platform to discover innovative diagnostic tests for clinical use. Our technology agnostic approach allows for a broader and more holistic understanding of each patient’s disease state. Additionally, we provide biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics.

See more information at www.biodesix.com.